Anesthesia Drugs – Worldwide Markets

Description

An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues to grow, increased competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas of the world. New products in development may change the market landscape dramatically.

The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The issues and trends addressed in the anesthesia drug market include:

Regulation of Anesthesia Drugs

Dentistry and Anesthesia

Anesthesia and Pediatric Applications

Anesthesia and Benefits to Depressed Patients

Anesthesia and Sleep

Gender Differences in Anesthesia Reaction

Trends in Conscious Sedation

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study

Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2006. Historical data is provided for the years 2004 and 2005, with forecast data provided for 2007 through 2011. Compound annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and 2004-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006 with a projected competitive analysis for 2011.

The forecasted market analysis for 2007-2011 is based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

As part of its market coverage, the following companies were profiled in this report:

Abbott Laboratories

Abraxis BioScience, Inc.

Anesiva, Inc.

Baxter International, Inc

B. Braun Melsungen AG

Dentsply International, Inc.

Endo Pharmaceuticals Holdings, Inc.

Hospira, Inc.

MGI Pharma, Inc

Minrad International, Inc.

Organon N.V.

Roche

SkyePharma plc

TEVA

Table of Contents

Chapter One: Executive Summary

Introduction

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting Market

Leading Competitors

Chapter Two: Introduction The World Anesthesia

Drug Market

Introduction and History to Anesthesia Drugs

Types of Anesthesia

General Anesthesia

Local Anesthesia

Adjunctive Therapies in Anesthesia

Routes of Administration

Inhalation

Mask Inhalation

Laryngeal Mask

Endotracheal Administration

Controlled Respiration

Intravenous

Topical Application

Transdermal/Transmucosal Application

Distribution Channels

Demographics and Statistics

Worldwide Demographics

Procedures by Type

Complications in Anesthesia

Chapter Three: General Anesthesia

Overview

Induction of General Anesthesia

Preoxygenation

Loss of Consciousness

Description of Products

Diprivan

Ultane/Sevorane

Ethrane

Forane

Pentothal

Suprane

Ketalar

Brevital

Generic Drug Impact and Availability

Research and Development

Aquavan

Propofol IDD-D

Market Size and Growth

Competitive Analysis

Chapter Four: Local Anesthesia

Overview

Techniques of Administration

Topical Application

Transdermal/Transmucosal

Simple Local Infiltration

Regional Injections

Spinal and Epidural Anesthesia

Intrathecal Block

Epidural, Peridural Block

Description of Products

AminoAmides

Xylocaine/LidoSite/Lidoderm/Dentipatch

Carbocaine/Isocaine/Polocaine

Marcaine/Sensorcaine

Citanest

Naropin

Septocaine

Amino Esters

Novocaine

Cetacaine/Pontocaine

Nesacaine

Cocaine Hydrochloride

Strocain /Mucaine

Combinations

Synera/Pliaglis

EMLA

Duocaine

Exactacain

Generic Drug Impact and Availability

Research and Development

Market Size and Growth

Competitive Analysis

Chapter Five: Adjunctive Therapies in Anesthesia

Overview

Description of Products

Neuromuscular Blocking Agents

Preanesthetic Sedation and Anesthesia Maintenance

Anesthesia Reversal Agents

Generic Drug Impact and Availability

Research and Development

Market Size and Growth

Competitive Analysis

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

Total Market Size and Forecast

Competitor Analysis

Chapter Seven: Issues and Trends

Anesthesia Drug Market

Introduction

Regulation of Anesthesia Drugs

Dentistry and Anesthesia

Anesthesia and Complications in Pediatric Applications

Anesthesia and the Benefits to Depression Patients

Anesthesia and Sleep

Gender Differences in Anesthesia Reaction

Trends in Conscious Sedation

Chapter Eight: Corporate Profiles

Introduction

Abbott Laboratories

Abraxis BioScience, Inc

Anesiva, Inc.

Baxter International, Inc.

B. Braun Melsungen AG

Dentsply International, Inc.

Endo Pharmaceuticals Holdings, Inc

Hospira, Inc.

MGI Pharma, Inc.

Minrad International, Inc.

Organon N.V.

Roche.

SkyePharma plc

TEVA

Appendix: Anesthesia List of Companies

table of exhibits

Chapter One: Executive Summary

Table 1-1: The Market for Anesthesia Drugs 2004-2011

Figure 1-1: The Market for Anesthesia Drugs 2004-2011

Chapter Two: Introduction: The World Anesthesia Drug Market

Table 2-1: World Population by Selected Geographical Region, 2006-2050

Figure 2-1: World Population by Selected Geographical Region, 2006-2050

Table 2-2: Estimated World Population by Age and Geographical Region, 2006

Table 2-2: Estimated World Population by Age and Geographical Region, 2006

Sitemap

Your Data and Privacy

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.